Meet the winners of the Principal's Prize for Public Engagement through Media
Two members of the RI-MUHC distinguished
The Montreal Children’s Hospital launches the bilingual Opal patient portal app
In a Quebec first, a child’s medical info is just a click away
Understanding the health impact of inactivity for the benefit of older adults and astronauts
A study using bedrest as an analog to microgravity will provide data for eight Canadian research projects
Dr. Lucy Gilbert named to the Top Women of Influence™ in Canada for 2021
Dr. Gilbert's work on testing varian and endometrial cancers early is saving countless lives
When is dead really dead?
Dr. Sam Shemie leads the death prediction and physiology after removal of therapy study (DePPaRT study)
RI-MUHC researchers support Canada’s efforts to address the COVID-19 pandemic
Drs. Emily McDonald and Todd C. Lee are part of the Canadian Network of COVID-19 Clinical Trials Networks...
Two studies confirm efficiency of saliva tests for COVID-19
Testing is the cornerstone of the fight against COVID-19, and a test that can be self-administered would greatly increase the options for case...
Could an antidepressant slow COVID-19 progression?
RI-MUHC researchers launch a clinical trial of fluvoxamine, a drug that has already proven efficient in reducing lung injury in animal studies and...
Clinical Innovation Platform at the RI-MUHC announces first member company
Health tech accelerator welcomes AltPAP Innovation to its new state-of-the-art facility
The RI-MUHC leads new clinical trial of COVID-19 treatment for hospitalized patients
Phase 2 study tests LAU-7b, a Canadian drug with dual antiviral and inflammation-controlling effects